Regarding the topic of Resmed's Q1 FY26 earnings, this analysis is super insightful, clearly outlining how they beat expectations despite the slight deceleration in growth. It makes me curious about those manufacturing efficiencies and how much modern process optimisation or even AI integration contributes to the improved gross margins.
There’s two ways to answer your question. You can use Inferential Investor”s Earnings Call Transcript analysis tool to extract those insights in manufacturing and AI use from managements language on the call. Secondly when you use any of our AI workflows you can follow on with additional questions. With the initial information in the context window to help the model contextualize the query, you get very insightful answers.
Regarding the topic of Resmed's Q1 FY26 earnings, this analysis is super insightful, clearly outlining how they beat expectations despite the slight deceleration in growth. It makes me curious about those manufacturing efficiencies and how much modern process optimisation or even AI integration contributes to the improved gross margins.
There’s two ways to answer your question. You can use Inferential Investor”s Earnings Call Transcript analysis tool to extract those insights in manufacturing and AI use from managements language on the call. Secondly when you use any of our AI workflows you can follow on with additional questions. With the initial information in the context window to help the model contextualize the query, you get very insightful answers.